WallStreetZenWallStreetZen

NASDAQ: DRMA
Dermata Therapeutics Inc Earnings & Revenue

DRMA earnings and revenue history

Current Revenue
$0.0
Current Earnings
-$7.8M
Current Profit Margin
0%

DRMA Return on Equity

Current Company
-108%
Current Industry
-63.5%
Current Market
188%
DRMA's Return on Equity (-108%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when DRMA announces earnings.

DRMA Return on Assets

Current Company
-93.6%
Current Industry
2.9%
DRMA is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

DRMA Return on Capital Employed

Current Company
0%
Current Industry
19.5%

DRMA vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
DRMA$0.00-$7.79M-$7.79MN/AN/A
CYTO$0.00-$2.31M-$4.30MN/AN/A
NBY$14.73M-$9.44M-$16.70M+3.32%N/A
CYCC$420.00k-$25.52M-$22.76M+22.87%N/A
CNSP$0.00-$18.83M-$18.85MN/AN/A

DRMA earnings dates

Next earnings date
May 16, 2024

Dermata Therapeutics Earnings & Revenue FAQ

What were DRMA's earnings last quarter?

On Invalid Date, Dermata Therapeutics (NASDAQ: DRMA) reported Q4 2023 earnings per share (EPS) of -$0.21, up 89.29% year over year. Total Dermata Therapeutics earnings for the quarter were -$2.13 million. In the same quarter last year, Dermata Therapeutics's earnings per share (EPS) was -$1.96.

If you're new to stock investing, here's how to buy Dermata Therapeutics stock.

What was DRMA's earnings growth in the past year?

As of Q2 2024, Dermata Therapeutics's earnings has grown year over year. Dermata Therapeutics's earnings in the past year totalled -$7.79 million.

What is DRMA's earnings date?

Dermata Therapeutics's earnings date is Invalid Date. Add DRMA to your watchlist to be reminded of DRMA's next earnings announcement.

What was DRMA's revenue last quarter?

On Invalid Date, Dermata Therapeutics (NASDAQ: DRMA) reported Q4 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Dermata Therapeutics's revenue was $0.00.

What was DRMA's revenue growth in the past year?

As of Q2 2024, Dermata Therapeutics's revenue has grown null year over year. Dermata Therapeutics's revenue in the past year totalled $0.00.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.